Sp1032
PANEL DISCUSSION: TIPS AND TRICKS FOR PUBLISHING EDUCATION SCHOLARSHIP
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
The Academy of Educators serves to support the careers of educators in GI/Hepatology. Our annual plenary session is an opportunity for those who identify as educators to build skills, strengthen our community, and celebrate the work being done by our junior colleagues. We will have two presentations by expert colleagues on teaching skills and teaching scholarship. Then we will hear from our four grant winners about their ongoing work. There will be opportunities to network with colleagues, learn about the Academy's ongoing projects, and engage with our working groups.
The Academy of Educators serves to support the careers of educators in GI/Hepatology. Our annual plenary session is an opportunity for those who identify as educators to build skills, strengthen our community, and celebrate the work being done by our junior colleagues. We will have two presentations by expert colleagues on teaching skills and teaching scholarship. Then we will hear from our four grant winners about their ongoing work. There will be opportunities to network with colleagues, learn about the Academy's ongoing projects, and engage with our working groups.
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
